Back
Starbucks Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
44
SBUX
Starbucks
Last Price:
96.15
Seasonality Move:
8.08%
Sell
41
ASND
Ascendis Pharma AS
Last Price:
149.16
Seasonality Move:
6.54%
Sell
44
Starbucks (SBUX)
is a Sell
Is Starbucks a Buy, Sell or Hold?
- The current Starbucks [SBUX] share price is $96.44. The Score for SBUX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- SBUX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $146.59. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SBUX Stock Price Chart
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $146.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.
SBUX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.1 | Buy |
| Relative Strength Index (14 RSI): | 60.91 | Buy |
| Chaikin Money Flow: | 5325254 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (92.36 - 96.9) | Buy |
| Bollinger Bands (100): | (73.73 - 89.95) | Buy |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.42 | Sell |
| Relative Strength Index (14 RSI): | 66.82 | Buy |
| Chaikin Money Flow: | 1073571 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (121.38 - 142.52) | Buy |
| Bollinger Bands (100): | (125.48 - 139.4) | Buy |
SBUX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 95.69 | Buy |
| 20-day SMA: | 94.69 | Buy |
| 50-day SMA: | 84.87 | Buy |
| 200-day SMA: | 87.31 | Buy |
| 8-day EMA: | 96.11 | Buy |
| 20-day EMA: | 93.64 | Buy |
| 50-day EMA: | 88.31 | Buy |
| 200-day EMA: | 87.42 | Buy |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 122.89 | Buy |
| 20-day SMA: | 130.17 | Buy |
| 50-day SMA: | 132.66 | Buy |
| 200-day SMA: | 135.12 | Buy |
| 8-day EMA: | 128.84 | Buy |
| 20-day EMA: | 128.79 | Buy |
| 50-day EMA: | 131.25 | Buy |
| 200-day EMA: | 129.25 | Buy |
Starbucks Earnings Growth & SBUX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.07 per share, an increase this year of $0.11 per share, and an increase next year of $0.42 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.77 per share, an increase next quarter of $1.90 per share, an increase this year of $1.68 per share, and an increase next year of $4.41 per share.
Starbucks Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||